First Eagle Value in Biotechnology Master Fund, Ltd., 10% Owner at DURECT CORP (DRRX), bought 1,668,800 shares at $1.74 ($2.8M) on 2015-03-10, disclosed to the SEC on 2015-03-20.
Open-market purchase of $2.8M DRRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.69 | 300,000 | $507K | 17.9% |
| 2 | $1.74 | 500,000 | $870K | 30.7% |
| 3 | $1.69 | 400,000 | $676K | 23.8% |
| 4 | $1.69 | 200,000 | $338K | 11.9% |
| 5 | $1.66 | 168,800 | $280K | 9.9% |
| 6 | $1.66 | 100,000 |
| $166K |
| 5.9% |
| Total | $1.70 avg | 1,668,800 | $2.8M | 100% |
| Filing → |
| IVAC | SELL | 2017-05-02 | $432K | — | Filing → |
| DRRX | BUY | 2016-04-27 | $6.9M | — | Filing → |